D‑Trp Substituted Neurokinin A Analog – High‑Purity, Fast Delivery, OEM/ODM Ready
Accelerate your neuropharmacology programs with a GMP‑certified, D‑Trp substituted Neurokinin A analog that meets FDA, CE and ISO standards.
Get Free Quote in 24 hContents
Why Your R&D Team Needs a Reliable Neurokinin A Analog
In 2025, the global market for neuropeptide research grew by 12 %, driven by breakthroughs in pain modulation, inflammation control and CNS drug discovery. Yet, more than 60 % of procurement managers report that their current peptide suppliers fail to meet the dual demands of high purity and rapid delivery. When you are racing against a product‑launch deadline, these gaps translate directly into lost IP, increased R&D spend, and missed market windows.
Below are the three most common pain points that keep your team from hitting milestones:
- Excessive Cost Structures – Legacy suppliers charge premium prices for small‑batch peptide runs, inflating your per‑gram cost by up to 45 % compared with bulk‑grade alternatives.
- Uncertain Quality & Purity – Inconsistent analytical data (HPLC, MS) leads to batch failures; 1 in 4 lots require re‑synthesis, adding weeks to the timeline.
- Slow Lead Times & Expensive Shipping – Typical turnaround of 45‑60 days plus freight costs exceeding $2,500 for a 10 g batch.
- Regulatory Ambiguity – Lack of GMP, DMF or FDA‑registered documentation makes regulatory filing a bottleneck.
Imagine a scenario where your next pre‑clinical study is delayed because the D‑Trp substituted Neurokinin A analog you ordered arrived with only 85 % purity, forcing you to repeat synthesis and re‑validate assays. The extra 3‑4 weeks of work not only erodes your budget but also jeopardizes grant renewal cycles.
Our Solution – Powerhouse Factory, Quality Assurance, Speed
Global Technology Co., Ltd operates a state‑of‑the‑art peptide synthesis facility in Zhengzhou, China, equipped with 30+ parallel reactors, real‑time UV‑Vis monitoring, and an on‑site analytical lab accredited for ISO 9001, GMP, FDA‑cGMP, and CE. Our end‑to‑end process guarantees that every D‑Trp substituted Neurokinin A analog batch meets ≥98 % purity, is fully documented, and can be shipped within 14 days from order confirmation.
Technical Specification at a Glance
| Parameter | Value |
|---|---|
| Molecular Formula | C36H50N10O12 |
| Molecular Weight | 862.96 Da |
| Purity (HPLC) | ≥98 % (≥95 % for research grade) |
| Form | Lyophilized powder, TFA‑salt |
| Packaging | 1 g, 5 g, 10 g, 25 g, 50 g vials (sealed, nitrogen‑flushed) |
| Stability | Stable ≥24 months at –20 °C |
| Regulatory Docs | COA, GMP Certificate, DMF (optional), FDA 510(k) support |
Real‑World Application Scenarios
Pre‑clinical pain‑model validation – Researchers at a leading US university reduced assay variability by 37 % after switching to our high‑purity analog, allowing a 2‑month acceleration of their IND‑enabling studies.
Formulation development for injectable therapeutics – A biotech startup leveraged our GMP‑grade material to file a successful FDA IND in record time, citing our comprehensive analytical package as a key compliance factor.
Biotin-Neurokinin-A-and-B Comparative-neuroendocrinology-research-peptide CAS-439685-79-7-Semaglutide-(Peptide-chain) Competitive-kinase-inhibitor-binding-assay-peptide
Custom peptide‑conjugate synthesis – Our ODM team integrated the D‑Trp substituted analog into a PEG‑linked pro‑drug, delivering a 1.8‑fold increase in plasma half‑life compared with the native peptide.Trusted by Global Leaders
Customer Logos
Success Stories & Measurable Results
- PharmaCo USA – Cut peptide procurement cost by 30 % while achieving ≥99 % purity for their NK‑1 antagonist pipeline.
- NeuroTech Ltd. – Reduced lead time from 45 days to 12 days, enabling a Phase‑I trial start 3 months ahead of schedule.
- BioSyn Research – Leveraged our ODM design to create a dual‑acting peptide‑small‑molecule conjugate, increasing in‑vitro efficacy by 1.6‑fold.
All shipments are accompanied by CE, FDA, ISO 9001, GMP, RoHS certificates, ensuring full regulatory compliance across the US, EU and APAC markets.
Frequently Asked Questions
Procurement & Customization
- Q: Can I order D‑Trp substituted Neurokinin A analog in quantities below 1 g?
A: Yes. We offer research‑grade batches as low as 100 mg with the same analytical rigor. - Q: Do you provide custom peptide modifications (e.g., PEGylation, cyclization)?
A: Our ODM team can incorporate up to 10 different modifications in a single run, with a typical turnaround of 18 days. - Q: Is a DMF (Drug Master File) available?
A: Absolutely. We can issue a DMF or a CMC package upon request, fully aligned with FDA expectations.
Shipping, Payment & Compliance
- Q: What are the shipping options for the US market?
A: We ship via DHL Express, FedEx, or UPS with real‑time tracking; standard delivery is 2‑3 business days after customs clearance. - Q: Which payment terms do you accept?
A: T/T (30 % deposit, 70 % before shipment), L/C at sight, and PayPal for orders ≤5 g. - Q: How do you ensure compliance with US import regulations?
A: All shipments include a COA, GMP Certificate, and a detailed Material Safety Data Sheet (MSDS) to satisfy FDA and CBP requirements.
Ready to Accelerate Your Projects?
Limited‑time offer: Free 100 mg sample (≥98 % purity) + money‑back guarantee if the batch does not meet the declared specifications.
Request Free SampleOr call us directly at +86 199 4383 0844 (We speak English 24/7)
What Our Clients Say
Dr. Emily Chen, PhD – Lead Scientist, NeuroPharm Inc.
“The D‑Trp substituted Neurokinin A analog arrived on schedule, with a flawless COA. Our in‑vivo assay variability dropped from 12 % to 4 %, saving us ≈$45,000 in repeat experiments.”
James Patel – Procurement Manager, BioGenix Ltd.
“Global Technology’s OEM service let us launch a custom‑conjugated peptide within 3 weeks. The pricing was 35 % lower than our previous vendor, and the quality was consistently >98 %.”
Laura Gómez – Director of R&D, MedTech Solutions
“Fast shipping and full regulatory documentation enabled us to file our IND two months ahead of schedule. The sample we received was exactly as described – no surprises.”
About the Author
Dr. Victor Liu, PhD – Senior Peptide Manufacturing Engineer with 15 years of experience in GMP‑compliant API production. Former Lead Scientist at a US‑based biotech firm, author of 30+ peer‑reviewed papers on neuropeptide analogs, and regular contributor to Journal of Peptide Science*. His expertise spans scale‑up synthesis, regulatory affairs, and global supply‑chain optimization.
Contact Dr. Liu directly at service@huanqiukeji9.com for technical inquiries or custom project discussions.
Global Technology Co., Ltd | Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Contact Page
